Sumedh Thakar sells QLYS shares under 10b5-1 plan (QLYS)
Rhea-AI Filing Summary
QuantumLeap (QLYS) Section 144 notice shows Sumedh Thakar intends to sell up to 30,000 shares of Common Stock (PSU/RSU issued 02/05/2024). The excerpt lists recent 10b5-1 sales in June 2026: 10,000 shares on 06/29/2026 for $1,267,537.00, 10,000 shares on 06/26/2026 for $1,204,814.00, 3,200 shares on 06/15/2026 for $367,368.96, and 13,200 shares on 06/01/2026 for $1,514,407.36. The filing identifies the sales as executed under a 10b5-1 Sales Plan.
Positive
- None.
Negative
- None.
Insights
Notice lists a proposed resale of PSU/RSU and recent plan-driven dispositions.
The filing states 30,000 shares of Common Stock (PSU/RSU issued 02/05/2024) are covered for sale and enumerates multiple executed sales under a 10b5-1 Sales Plan in June 2026. Cash proceeds for each trade are shown.
These entries document reported dispositions under a trading plan; cash‑flow treatment and any remaining unregistered balance beyond the stated 30,000 shares are not described in the provided excerpt.
Transactions are administrative disclosures of planned insider sales, not new corporate actions.
The submission is a Section 144-style notice listing holder identity, security type (PSU/RSU), issuance date, and specific 10b5-1 sale executions with dates and amounts. It records that sales occurred pursuant to a plan rather than ad hoc open-market trades.
Impact on equity structure is not quantified here; subsequent filings or transaction-level reports would show remaining holdings and any additional regulatory notices.